MEASURING HEALTH-RELATED QUALITY-OF-LIFE

被引:2677
作者
GUYATT, GH [1 ]
FEENY, DH [1 ]
PATRICK, DL [1 ]
机构
[1] UNIV WASHINGTON, SCH PUBL HLTH & COMMUNITY MED, DEPT HLTH SERV, SEATTLE, WA 98195 USA
关键词
QUALITY OF LIFE; HEALTH POLICY; HEALTH STATUS INDICATORS; QUESTIONNAIRES; HEALTH STATUS;
D O I
10.7326/0003-4819-118-8-199304150-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinicians and policymakers are recognizing the importance of measuring health-related quality of life (HRQL) to inform patient management and policy decisions. Self- or interviewer-administered questionnaires can be used to measure cross-sectional differences in quality of life between patients at a point in time (discriminative instruments) or longitudinal changes in HRQL within patients during a period of time (evaluative instruments). Both discriminative and evaluative instruments must be valid (really measuring what they are supposed to measure) and have a high ratio of signal to noise (reliability and responsiveness, respectively). Reliable discriminative instruments are able to reproducibly differentiate between persons. Responsive evaluative measures are able to detect important changes in HRQL during a period of time, even if those changes are small. Health-related quality of life measures should also be interpretable-that is, clinicians and policymakers must be able to identify differences in scores that correspond to trivial, small, moderate, and large differences. Two basic approaches to quality-of-life measurement are available: generic instruments that provide a summary of HRQL; and specific instruments that focus on problems associated with single disease states, patient groups, or areas of function. Generic instruments include health profiles and instruments that generate health utilities. The approaches are not mutually exclusive. Each approach has its strengths and weaknesses and may be suitable for different circumstances. Investigations in HRQL have led to instruments suitable for detecting minimally important effects in clinical trials, for measuring the health of populations, and for providing information for policy decisions.
引用
收藏
页码:622 / 629
页数:8
相关论文
共 40 条
[1]  
APTRICK DL, 1993, HLTH STATUS HLTH POL
[2]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[4]   AURANOFIN THERAPY AND QUALITY-OF-LIFE IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF A MULTICENTER TRIAL [J].
BOMBARDIER, C ;
WARE, J ;
RUSSELL, IJ ;
LARSON, M ;
CHALMERS, A ;
READ, JL .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (04) :565-578
[5]   ECONOMIC-EVALUATION OF NEONATAL INTENSIVE-CARE OF VERY-LOW-BIRTH-WEIGHT INFANTS [J].
BOYLE, MH ;
TORRANCE, GW ;
SINCLAIR, JC ;
HORWOOD, SP .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (22) :1330-1337
[6]   THE EFFECTS OF ANTIHYPERTENSIVE THERAPY ON THE QUALITY-OF-LIFE [J].
CROOG, SH ;
LEVINE, S ;
TESTA, MA ;
BROWN, B ;
BULPITT, CJ ;
JENKINS, CD ;
KLERMAN, GL ;
WILLIAMS, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1657-1664
[8]   MEASURING FUNCTIONAL OUTCOMES IN CHRONIC DISEASE - A COMPARISON OF TRADITIONAL SCALES AND A SELF-ADMINISTERED HEALTH-STATUS QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
DEYO, RA ;
INUI, TS ;
LEININGER, JD ;
OVERMAN, SS .
MEDICAL CARE, 1983, 21 (02) :180-192
[9]   PROCEEDINGS OF THE INTERNATIONAL-CONFERENCE ON THE MEASUREMENT OF QUALITY-OF-LIFE AS AN OUTCOME IN CLINICAL-TRIALS - JUNE 14-17, 1989 - INTRODUCTION [J].
FEENY, D ;
GUYATT, G ;
PATRICK, D .
CONTROLLED CLINICAL TRIALS, 1991, 12 (04) :S79-S80
[10]   A COMPREHENSIVE MULTIATTRIBUTE SYSTEM FOR CLASSIFYING THE HEALTH-STATUS OF SURVIVORS OF CHILDHOOD-CANCER [J].
FEENY, D ;
FURLONG, W ;
BARR, RD ;
TORRANCE, GW ;
ROSENBAUM, P ;
WEITZMAN, S .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (06) :923-928